The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to the complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2021-2030.”
To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/oligonucleotide-synthesis/request-sample.html
The report features a detailed study of the current scenario and future potential of the custom synthesis, modification and purification services market for oligonucleotides, which are intended for research, diagnostic, and therapeutic applications. Further, the study underlines an in-depth analysis, highlighting the capabilities of service providers engaged in this domain. In addition to other elements, the study covers:
- A detailed assessment of the current market landscape of oligonucleotide manufacturers focused on research and diagnostic and therapeutic applications.
- An insightful company competitiveness analysis, highlighting the key oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications, based on supplier strength and service strength.
- Elaborate profiles of key players engaged in offering custom synthesis, modification and purification of oligonucleotides for research and diagnostic, and therapeutic applications.
- A qualitative analysis highlighting the various factors that need to be considered by players engaged in this domain, while deciding whether to manufacture their respective products in-house or engage the services of a service provider.
- A detailed review of the various oligonucleotide-based manufacturing initiatives undertaken by big pharma players (on the basis of revenues generated by top 5 pharmaceutical companies in 2020).
- An analysis of recent partnerships inked between players engaged in oligonucleotide manufacturing, during the period 2014-2021.
- An analysis of the various expansion initiatives undertaken by service providers engaged in this domain, during the period 2016-2021.
- An in-depth analysis of over 90 oligonucleotide-based therapy developers that are likely to partner with contract service providers engaged in this domain.
- A detailed analysis of more than 440 completed and ongoing clinical research studies of various oligonucleotide-based drugs.
- An estimate of the global, installed capacity for the manufacturing of oligonucleotides, based on information provided by various industry stakeholders in the public domain.
- An informed estimate of the annual commercial demand for oligonucleotide-based drugs (in kilograms).
- An elaborate discussion on how the recent COVID-19 pandemic is likely to impact the oligonucleotide synthesis market, along with information on the key initiatives undertaken by players engaged in this domain to overcome the challenges faced due to the pandemic.
- A discussion on affiliated trends, key drivers and challenges, under an elaborate SWOT framework, which are likely to impact the industry’s evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
- A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing custom synthesis, modification and purification services for oligonucleotides.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Application Area
- Research and Diagnostic Applications
- Therapeutic Applications
- Type of Oligonucleotide
- Antisense Oligonucleotides
- miRNA
- shRNA
- siRNA
- Others
- Scale of Operation
- Clinical
- Commercial
- Purpose of Production
- In-house Operations
- Outsourced Operations
- Type of Operation
- API
- FDF
- Size of Manufacturer
- Small
- Mid-sized
- Large
- Key Therapeutic Areas
- Autoimmune Disorders
- Cardiovascular Disorders
- Genetic Disorders
- Infectious Diseases
- Metabolic Disorders
- Neuromuscular Disorders
- Oncological Disorders
- Ophthalmic Disorders
- Other Therapeutic Areas
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific and the Rest of the World
Key companies covered in the report
- Agilent Technologies
- Ajinomoto Bio-Pharma Services
- BioSpring
- CordenPharma
- Integrated DNA Technologies
- Kaneka Eurogentec
- LGC Biosearch Technologies
- Lonza
- Microsynth
- Nitto Denko Avecia
- Sigma Aldrich
- STA Pharmaceutical
- Sumitomo Chemical
- Thermo Fisher Scientific
- TriLink Biotechnologies
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Other Recent Offerings
- Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030
- Biopharmaceutical Contract Manufacturing Market (4th Edition), 2021-2030
- Antisense Oligonucleotide Therapeutics Market, 2020-2030
- RNAi Therapeutics Market (2nd Edition), 2019 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
